智通财经获悉，GE HealthCare (GEHC.US)已同意从Sumitomo Chemical手中收购Nihon Medi-Physics (NMP)剩余50%的股份，旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。该交易预计将对GE HealthCare第一年的调整后每股收益产生中性影响，此后将增加收益。

GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, ...

Sumitomo Chemical Co (JP:4005) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

智通财经获悉，GE HealthCare(GEHC.US)已同意从Sumitomo Chemical手中收购Nihon ...

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

This week, the FDA issued recommendations for streamlining the clearance process for AI-powered medical devices. The memo announcing this change recognizes that the utilization of AI in devices “is an ...

GE HealthCare (GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics ((NMP)) from Sumitomo Chemical. Read ...

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As ...

GE HealthCare to buy remaining 50% stake in Japanese radiopharmaceutical company, Nihon Medi-Physics from Sumitomo Chemical: Chalfont St Giles, UK Monday, December 2, 2024, 14:00 ...